← All trials
NCT06856525
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 6, 2024
- Primary completion
- Dec 31, 2028
- Completion date
- Dec 31, 2032
- First posted
- Mar 4, 2025
- Last posted
- Mar 4, 2025
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of VirginiaLead sponsor
- Duke UniversityCollaborator
- University of VirginiaOfficial
- George Mason UniversityCollaborator
- University of VirginiaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.